British physician and microbiologist Alexander Fleming, discoverer of penicillin nearly 100 years ago, was the first to warn ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...

Following Pope Francis’ diagnosis of bilateral pneumonia, respiratory doctors are speaking about the condition. The Vatican ...

Infex Therapeutics, the Alderley Park-based anti-infectives specialist, has been awarded a £1m grant, alongside Germany’s ...

Cornell researchers have identified a key protein mechanism that helps bacteria expel antibiotics, making them more resistant ...

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Promimic has previously seen an effect on reduced adhesion of bacteria on HA nanoSurface, but the recent results also show a reduction of bacterial growth. The results indicate that the effect is ...

A new study is exploring the use of Random Antimicrobial Peptide Mixtures (RPMs) as a safe and effective alternative to ...